Search results for " transfusion"

showing 10 items of 148 documents

Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia

2021

AdultMaleRiskPediatricsmedicine.medical_specialtyIron OverloadAnemiabusiness.industryThalassemiabeta-ThalassemiaAnemiaHematologyKaplan-Meier Estimatemedicine.diseaseYoung AdultTransfusion dependencemedicineRisk of mortalityHumansBlood TransfusionFemaleMortalitybusinessHuman
researchProduct

Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial.

2005

<i>Background:</i> Patients with chronic urticaria (CU) frequently exhibit positive skin test reactions to autologous serum (ASST). Therapies aimed at inducing tolerance to circulating histamine-releasing factors in ASST+ CU patients, e.g. by treatment with autologous whole blood (AWB), have not yet been tested. <i>Objective:</i> To test whether ASST+ CU patients can benefit from repeated low-dose intramuscular injections of AWB. <i>Methods:</i> We characterized CU severity and duration, anti-Fc<sub>Ε</sub>RI and anti-IgE expression, use of antihistamines, and quality of life in 56 CU patients (ASST+: 35, ASST–: 21) and assessed the t…

AdultMaleSerummedicine.medical_specialtyUrticariaImmunoblottingPlacebo-controlled studyEnzyme-Linked Immunosorbent AssayDermatologymedicine.disease_causePlaceboGastroenterologyAutoimmunityAutohemotherapyBlood Transfusion AutologousInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesChronic urticariaWhole bloodSkin Testsbusiness.industryReceptors IgEImmunoglobulin EMiddle AgedSurgeryAntibodies Anti-IdiotypicClinical trialTreatment OutcomePatient SatisfactionChronic DiseaseQuality of LifeAutologous serum skin testFemalebusinessFollow-Up StudiesDermatology (Basel, Switzerland)
researchProduct

Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplant…

2001

We investigated whether a T cell-reduced allogeneic stem cell transplant (SCT) with minimal conditioning and subsequent donor lymphocyte infusions (DLI) could reduce the incidence and severity of GVHD while retaining stable engraftment. Five patients with hematological malignancies (three MM, one CLL, one Chediak-Higashi syndrome) were conditioned with TBI (200 cGy). One patient additionally received fludarabine (120 mg/m(2)). CsA and mofetyl-mycophenolate (MMF) were administered to prevent GVHD. All patients were grafted with >3 x 10(6)/kg highly purified CD34(+) cells together with 2 x 10(6)/kg CD3(+) cells (three patients) or 1 x 10(5)/kg CD3(+) cells (two patients). Quick hematopoietic …

AdultMaleTime FactorsLymphocyte TransfusionT-LymphocytesT cellLymphocyteChronic lymphocytic leukemiamedicine.medical_treatmentHematopoietic stem cell transplantationLymphocyte DepletionFatal OutcomemedicineHumansTransplantation HomologousTreatment FailureTransplantation ChimeraTransplantationbusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle AgedMycophenolic Acidmedicine.diseaseLeukemia Lymphocytic Chronic B-CellPeripheral stem cell transplantationFludarabineTransplantationmedicine.anatomical_structureHematologic NeoplasmsLymphocyte TransfusionImmunologyCyclosporineFemaleChediak-Higashi SyndromeMultiple MyelomabusinessImmunosuppressive AgentsVidarabineWhole-Body IrradiationFollow-Up Studiesmedicine.drugBone Marrow Transplantation
researchProduct

A complication risk score to evaluate clinical severity of thalassaemia syndromes

2020

The thalassaemia syndromes (TS) show different phenotype severity. Developing a reliable, practical and global tool to determine disease severity and tailor treatment would be of great value. Overall, 7910 patients were analysed with the aim of constructing a complication risk score (CoRS) to evaluate the probability of developing one or more complications. Nine independent variables were included in the investigation as predictors. Logistic regression models were used for Group A [transfusion-dependent thalassaemia (TDT)], Group B [transfused non-TDT (NTDT)] and Group C (non-transfused NTDT). Statistically significant predictors included age (years), haemoglobin levels, hepatic transaminas…

AdultMalemedicine.medical_specialtyAdolescentcomplicationsthalassaemiacomplicationrisk scoreLogistic regressionSeverity of Illness IndexGroup AGroup BHemoglobinsYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansprognostic modelBlood TransfusionClinical severityHemoglobinFramingham Risk ScoreEjection fractionReceiver operating characteristicbusiness.industryHematologyMiddle AgedPrognosisChelation TherapyThalassemia ...ROC Curve030220 oncology & carcinogenesisThalassemiaFemalecomplications; prognostic model; risk score; thalassaemiaComplicationbusiness030215 immunologyBritish Journal of Haematology
researchProduct

Use of topical tranexamic acid in primary total hip arthroplasty. Efficiency and safety. Our experience.

2019

Abstract Background and aim Intravenous tranexamic acid has been shown to reduce bleeding and the need for transfusions in total hip arthroplasty, although it has a theoretical risk of producing thromboembolic phenomena. Recently some papers have been published using the topical application of tranexamic acid, but the ideal administration protocol has not yet been clearly defined. The aim of this paper was to demonstrate that our protocol of topical tranexamic acid is effective and safe. Methods Prospective data collection from a case series of 80 primary hip arthroplasties, in which the following topical tranexamic acid protocol is used: 1.5 g diluted to a total volume of 60 ml were admini…

AdultMalemedicine.medical_specialtyBlood transfusionAdministration TopicalArthroplasty Replacement Hipmedicine.medical_treatmentBlood Loss SurgicalProspective data030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineClinical ProtocolsmedicineHumansBlood TransfusionOrthopedics and Sports MedicineProspective StudiesAged030222 orthopedicsAdministración tópica Artroplastia total cadera Topical administration Total hip arthroplasty Tranexamic acid Ácido tranexámicobusiness.industryFemoral canalMiddle AgedAntifibrinolytic AgentsSurgeryTreatment Outcomemedicine.anatomical_structureTranexamic AcidAcido tranexamicoFemaleSurgerybusinessTranexamic acidmedicine.drugTotal hip arthroplasty
researchProduct

Totally laparoscopic liver resections for primary and metastatic cancer in the elderly: safety, feasibility and short-term outcomes.

2012

Standard oncologic liver resections performed on elderly patients (≥70 years old) have been shown to be safe and effective. The aim of this study was to analyze operative and oncologic short-term outcomes of totally laparoscopic liver resections (TLLR) performed on elderly patients for malignancies. We performed a retrospective statistical analysis of prospectively recorded data of TLLR performed from October 2008 to February 2012 by a single hepato-pancreato-biliary (HPB) surgeon. Patients were divided into two groups according to age (<70 vs. ≥70 years old) and perioperative outcomes were compared. A total of 60 TLLR for malignancies were identified of which 25 patients (42 %) were aged ≥…

AdultMalemedicine.medical_specialtyBlood transfusionCarcinoma HepatocellularCritical Caremedicine.medical_treatmentOperative TimePostoperative ComplicationsmedicineHepatectomyHumansLiver neoplasmProspective StudiesProspective cohort studyAgedRetrospective StudiesAged 80 and overbusiness.industryMortality rateLiver NeoplasmsRetrospective cohort studyPerioperativeLength of StayMiddle AgedLAPAROSCOPIC LIVER RESECTIONS METASTATIC CANCERSurgeryTreatment OutcomeSurgeryFemaleLaparoscopyHepatectomyNeoplasm Recurrence LocalbusinessAbdominal surgerySurgical endoscopy
researchProduct

Prognostic factors for cryotherapy of colorectal liver metastases.

2004

Abstract Background . Cryotherapy is a local ablative treatment option for non-resectable liver tumours. We aimed to identify prognostic indicators, that may allow better selection or stratification for adjuvant therapies of patients. Methods . Fifty-five patients had cryotherapy for colorectal liver metastases. The patient-, tumour- and operative details were recorded prospectively. Mean follow up was 24 months. A uni- and multivariate analysis for possible prognostic factors was performed. Results . There was a trend towards better survival for patients with unilobar liver metastases, preoperative serum levels of carcinoembrional antigen (CEA) not exceeding 20 ng/ml and patients undergoin…

AdultMalemedicine.medical_specialtyBlood transfusionMultivariate analysisColorectal cancermedicine.medical_treatmentCryotherapyGastroenterologyCryosurgeryCryosurgeryInternal medicinemedicineHumansAgedUnivariate analysisbusiness.industryProportional hazards modelLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryCarcinoembryonic AntigenSurvival RateOncologySurgeryFemalebusinessColorectal NeoplasmsAdjuvantBiomarkersEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Anastomotic leakage after colon cancer resection: does the individual surgeon matter?

2016

Aim Anastomotic leakage is one of the most feared complications after colonic resection. Many risk factors for anastomotic leakage have been reported, but the impact of an individual surgeon as a risk factor has scarcely been reported. The aim of this study was to assess if the individual surgeon is an independent risk factor for anastomotic leakage in colonic cancer surgery. Method This was a retrospective analysis of prospectively collected data from patients who underwent elective resection for colon cancer with anastomosis at a specialized colorectal unit from January 1993 to December 2010. Anastomotic leaks were diagnosed according to standardized criteria. Patient and tumour character…

AdultMalemedicine.medical_specialtyBlood transfusionindividual surgeonColonColorectal cancermedicine.medical_treatmentAnastomotic Leak030230 surgeryAnastomosis03 medical and health sciences0302 clinical medicineIleorectal anastomosisRisk FactorsTask Performance and AnalysisColon cancer resectionHumansAnastomotic leakMedicineBlood TransfusionRisk factorcolon resectionColectomyAgedRetrospective StudiesAged 80 and overbusiness.industryAnastomosis SurgicalGastroenterologyPerioperativeMiddle Agedmedicine.diseaseSurgeryrisk factorcolon cancerElective Surgical ProceduresAnastomotic leakage030220 oncology & carcinogenesisColonic NeoplasmsFemaleClinical CompetencebusinessColorectal Disease
researchProduct

Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial

2014

Blood transfusion and iron chelation currently represent a supportive therapy to manage anemia, vasculopathy and vaso-occlusion crises in Sickle-Cell-Disease. Here we describe the first 5-year long-term randomized clinical trial comparing Deferiprone versus Deferoxamine in patients with Sickle-Cell-Disease. The results of this study show that Deferiprone has the same effectiveness as Deferoxamine in decreasing body iron burden, measured as repeated measurements of serum ferritin concentrations on the same patient over 5-years and analyzed according to the linear mixed-effects model (LMM) (p=0.822). Both chelators are able to decrease, significantly, serum ferritin concentrations, during 5-y…

AdultMalemedicine.medical_specialtyIron OverloadBlood transfusionAdolescentPyridonesAnemiaIronmedicine.medical_treatmentAnemia Sickle CellDeferoxamineIron Chelating AgentsGastroenterologylaw.inventionchemistry.chemical_compoundBasal (phylogenetics)Randomized controlled triallawInternal medicineHumansMedicineBlood TransfusionDeferiproneChildMolecular Biologybusiness.industryCell BiologyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryDeferoxamineItalychemistrySupportive psychotherapyFerritinsCohortLinear ModelsMolecular MedicineFemalebusinessDeferipronemedicine.drugBlood Cells, Molecules, and Diseases
researchProduct

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelof…

2010

The International Prognostic Scoring System (IPSS) and karyotype are useful tools for risk stratification in primary myelofibrosis (PMF). We examined the additional prognostic impact of red blood cell transfusion need among 254 consecutive patients (median age, 59 years). Sixty-two patients ( approximately 24%) required transfusions at diagnosis whereas 22 ( approximately 9%) became transfusion-dependent and 170 remained transfusion-independent during the first year postdiagnosis; after a median follow-up of 55 months, the respective median survivals were 35, 25, and 117 months (P < 0.01). Multivariable analysis confirmed the IPSS- and karyotype-independent prognostic weight of transfusion …

AdultMalemedicine.medical_specialtytransfusion myelofibrosisPROGNOSISmedicine.medical_treatmentmyelofibrosisHematopoietic stem cell transplantationSeverity of Illness IndexSettore MED/15 - Malattie Del SangueRisk FactorsInternal medicineSeverity of illnessmedicineHumansMyelofibrosisSurvival analysisAgedRetrospective StudiesAged 80 and overChromosome AberrationsHematologybusiness.industryPatient SelectionMyelodysplastic syndromesHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryPrimary MyelofibrosisInternational Prognostic Scoring SystemRBC transfusiion; myelofibrosis; PROGNOSISFemaleErythrocyte TransfusionbusinessFollow-Up StudiesRBC transfusiionAmerican Journal of Hematology
researchProduct